ResMed Inc.RMDNYSE
Loading
Book Value/Share Growth TrendStable
Percentile Rank44
3Y CAGR-27.9%
5Y CAGR-13.4%
Year-over-Year Change
Year-over-year book value per share growth
3Y CAGR
-27.9%/yr
vs +57.8%/yr prior
5Y CAGR
-13.4%/yr
Recent deceleration
Acceleration
-85.7pp
Decelerating
Percentile
P44
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
1 qtr
Consecutive growthStable
| Period | Value |
|---|---|
| Q4 2025 | 3.26% |
| Q3 2025 | 2.57% |
| Q2 2025 | 7.79% |
| Q1 2025 | 5.68% |
| Q4 2024 | 1.12% |
| Q3 2024 | 6.84% |
| Q2 2024 | 5.09% |
| Q1 2024 | 3.43% |
| Q4 2023 | 5.41% |
| Q3 2023 | 2.88% |
| Q2 2023 | 4.95% |
| Q1 2023 | 5.05% |
| Q4 2022 | 8.69% |
| Q3 2022 | 2.09% |
| Q2 2022 | 2.42% |
| Q1 2022 | 4.05% |
| Q4 2021 | 3.74% |
| Q3 2021 | 4.81% |
| Q2 2021 | 6.32% |
| Q1 2021 | -5.49% |
| Q4 2020 | 6.69% |
| Q3 2020 | 7.20% |
| Q2 2020 | 10.54% |
| Q1 2020 | -0.37% |
| Q4 2019 | 6.29% |
| Q3 2019 | 1.97% |
| Q2 2019 | 2.43% |
| Q1 2019 | 3.05% |
| Q4 2018 | 2.75% |
| Q3 2018 | -7.63% |
| Q2 2018 | -0.31% |
| Q1 2018 | 2.22% |
| Q4 2017 | -1.79% |
| Q3 2017 | 4.39% |
| Q2 2017 | 5.45% |
| Q1 2017 | 8.16% |
| Q4 2016 | -3.88% |
| Q3 2016 | 4.28% |
| Q2 2016 | 1.15% |
| Q1 2016 | 9.58% |